KEQU Kewaunee Scientific Corporation

Price (delayed)

$35.72

Market cap

$102.53M

P/E Ratio

10.63

Dividend/share

N/A

EPS

$3.36

Enterprise value

$147.73M

?
Relative Growth: Rel. Growth: 72
Relative Strength: Rel. Strength: 26
Relative Valuation: Rel. Valuation: 88
Relative Profitability: Rel. Profitability: 48

Founded in 1906, Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. The Company's portfolio includes laboratory casework, ...

Highlights
Kewaunee Scientific's debt has decreased by 27% YoY and by 4.3% from the previous quarter
The revenue rose by 17% year-on-year
KEQU's gross profit is up by 17% year-on-year but it is down by 3.4% since the previous quarter
KEQU's EPS is down by 16% year-on-year and by 13% since the previous quarter
The net income has declined by 16% year-on-year and by 13% since the previous quarter

Key stats

What are the main financial stats of KEQU

KEQU stock price

How has the Kewaunee Scientific stock price performed over time
Intraday
-3.04%
1 week
-0.81%
1 month
0.56%
1 year
-35.45%
YTD
-4.52%
QTD
0.56%

Financial performance

How have Kewaunee Scientific's revenue and profit performed over time
Revenue
$282M
Gross profit
$80.44M
Operating income
$16.72M
Net income
$9.62M
Gross margin
28.5%
Net margin
3.4%
Kewaunee Scientific's net margin has decreased by 28% YoY and by 13% from the previous quarter
The operating margin has decreased by 20% YoY and by 16% from the previous quarter
KEQU's gross profit is up by 17% year-on-year but it is down by 3.4% since the previous quarter
The revenue rose by 17% year-on-year

Price vs fundamentals

How does KEQU's price correlate with its fundamentals

Growth

What is Kewaunee Scientific's growth rate over time

Valuation

What is Kewaunee Scientific stock price valuation
P/E
10.63
P/B
1.37
P/S
0.36
EV/EBIT
8.82
EV/EBITDA
6.42
EV/Sales
0.52
KEQU's EPS is down by 16% year-on-year and by 13% since the previous quarter
KEQU's P/E is 4.2% below its last 4 quarters average of 11.1
KEQU's price to book (P/B) is 24% lower than its last 4 quarters average of 1.8 and 14% lower than its 5-year quarterly average of 1.6
KEQU's equity is up by 16% YoY and by 6% from the previous quarter
The revenue rose by 17% year-on-year
KEQU's price to sales (P/S) is 10% lower than its 5-year quarterly average of 0.4 and 10% lower than its last 4 quarters average of 0.4

Efficiency

How efficient is Kewaunee Scientific business performance
The ROE fell by 28% YoY and by 17% QoQ
Kewaunee Scientific's return on assets has decreased by 26% YoY and by 12% QoQ
KEQU's return on sales is down by 20% year-on-year and by 14% since the previous quarter
The ROIC has contracted by 18% YoY and by 13% from the previous quarter

Dividends

What is KEQU's dividend history
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
Dividend history

Special dividends are included in TTM DPS and yield

Financial health

How did Kewaunee Scientific financials performed over time
Kewaunee Scientific's total assets is 76% more than its total liabilities
The total liabilities has decreased by 21% YoY
The quick ratio has grown by 11% from the previous quarter
Kewaunee Scientific's debt is 24% less than its equity
KEQU's debt to equity is down by 37% year-on-year and by 10% since the previous quarter
Kewaunee Scientific's debt has decreased by 27% YoY and by 4.3% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.